Synovus Financial Corp Haemonetics Corp Transaction History

Synovus Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$51.81 - $118.56 $204,701 - $468,430	-3,951 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$111.01 - $139.48 $30,416 - $38,217	274 Added 7.45%	3,951 $436,000
Q4 2020 Feb 11, 2021	BUY	$88.75 - $119.95 $91,235 - $123,308	1,028 Added 38.81%	3,677 $434,000
Q3 2020 Nov 09, 2020	SELL	$75.65 - $93.58 $349,049 - $431,778	-4,614 Reduced 63.53%	2,649 $229,000
Q2 2020 Aug 10, 2020	BUY	$84.96 - $118.91 $617,064 - $863,643	7,263 New	7,263 $650,000

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.97B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.